Status | Study |
RECRUITING |
Study Name: Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP Condition: Idiopathic Thrombocytopenic Purpura Date: 2022-01-21 Interventions: Once a week as a subcutaneous injection.The initial dose is 1 mcg/kg. |
Recruiting |
Study Name: Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools) Condition: Idiopathic Thrombocytopenic Purpura Date: 2017-04-12 Interventions: Other: completion of questionnaire completion of questionnaire for patient and parent |
Recruiting |
Study Name: Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients Condition: Chronic Idiopathic Thrombocytopenic Purpura Date: 2015-11-19 Interventions: Drug: Hetrombopag Olamine |
Completed |
Study Name: Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura Condition: Idiopathic Thrombocytopenic Purpura Immun Date: 2012-10-18 Interventions: Biological: Inactivated Trivalent Influenza vaccine |
Completed |
Study Name: Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Idiopathic Thrombocytopenic Purpura (ITP) Date: 2012-10-18 Interventions: Drug: rituximab infusion of 4 weekly doses of 375 mg/m2 rituximab |
Completed |
Study Name: Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura Condition: Idiopathic Thrombocytopenic Purpura Date: 2012-04-02 |
Terminated |
Study Name: A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura) Condition: Idiopathic Thrombocytopenic Purpura Date: 2011-09-13 Interventions: Drug: Eltrombopag Other Names: |
Recruiting |
Study Name: Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP) Condition: Idiopathic Thrombocytopenic Purpura Date: 2011-09-13 |
Completed |
Study Name: Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim Condition: Idiopathic Thrombocytopenic Purpura Date: 2010-06-10 Interventions: Biological: Romiplostim Romiplostim will be administered weekly by subcutaneous injection |
Active, not recruiting |
Study Name: The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP) Condition: Idiopathic Thrombocytopenic Purpura Date: 2009-05-26 Interventions: Drug: Dexamethasone Dexamethas |